Diabetic Retinopathy Assessed by Ultra-wide
NCT03157206 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 49
Last updated 2017-06-08
Summary
Patients with diabetic macular edema treated with aflibercept injections for visual impairment will be observed in standard care during 12 months. They will undergo visual assessments by Ultrawide Field angiography at baseline and at 12 months
Conditions
Sponsors & Collaborators
-
Association Pour La Recherche En Vision Du Service D'Ophtalmologie De L'Hôpital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-04-19
- Primary Completion
- 2019-07-18
- Completion
- 2020-09-18
Countries
- France
Study Locations
More Related Trials
-
Intravitreal Aflibercept Injection in Vision Impairment Due to DME
NCT01331681 ·Status: COMPLETED ·Phase: PHASE3
-
A Dose Ranging Study of OPT-302 With Aflibercept for Persistent Diabetic Macular Edema
NCT03397264 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Intravitreal Faricimab in Diabetic Macular Edema With Limited Response to Aflibercept
NCT05610488 ·Status: UNKNOWN ·Phase: PHASE4
-
Treatment of Diabetic Macular Edema With Aflibercept in Subjects Previously Treated With Ranibizumab or Bevacizumab
NCT02559180 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of the Effect of Intravitreal Injections of Anti-VEGF on Macular Perfusion in Diabetic Patients Using OCTA
NCT03246152 ·Status: COMPLETED ·Phase: PHASE4
-
Cytokine and Visual Outcome Variations in Eyes Receiving Aflibercept
NCT03056079 ·Status: UNKNOWN ·Phase: PHASE4
-
The Efficacy of Intravitreal Aflibercept Injection in Improvement of Retinal Nonperfusion in Diabetic Retinopathy
NCT03006081 ·Status: COMPLETED ·Phase: PHASE2
-
Screening For Diabetic Macular Edema Among Diabetic Patients Using Optical Coherence Tomography
NCT03240458 ·Status: UNKNOWN
-
Assessment of Biomarker Profile in Diabetic Macular Edema With Intravitreal Aflibercept Injection
NCT03297684 ·Status: UNKNOWN
-
Anti-vasculaR Endothelial Growth Factor plUs Anti-angiopoietin 2 in Fixed comBination therapY: Evaluation for the Treatment of Diabetic Macular Edema
NCT02712008 ·Status: COMPLETED ·Phase: PHASE2
-
Follow up of Diabetic Macular Edema Treated by Aflibercept (Eylea®) With OCT-Angiography
NCT03783832 ·Status: UNKNOWN
-
Anti-VEGF Treatment for Prevention of PDR/DME
NCT02634333 ·Status: COMPLETED ·Phase: PHASE3
-
A Blinded, Self-control Trial to Evaluate an Artificial Intelligence Based CAD System for Diabetic Retinography
NCT03973762 ·Status: COMPLETED ·Phase: NA
-
A Study to Assess the Effectiveness of Aflibercept in Routine Clinical Practice in Patients With Diabetic Macular Oedema
NCT02850263 ·Status: COMPLETED
-
Efficacy Analysis of Anti-VEGF Drugs Combined With Micropulse Laser in the Treatment of Diabetic Macular Edema
NCT05759884 ·Status: UNKNOWN ·Phase: NA
-
Epidemiologic Assessment of Diabetic Retinopathy in Egypt Using Ultrawide Field Fundus Photographs
NCT04935749 ·Status: RECRUITING
-
Combination of Standard Lucentis Therapy With Micropulse Diode Laser for the Treatment of Diabetic Macular Edema
NCT02059772 ·Status: UNKNOWN ·Phase: PHASE4
-
Aflibercept anD navigateD vErsus coNvensional Laser in Diabetic macUlar edeMa
NCT02554747 ·Status: COMPLETED ·Phase: NA
-
Changes in Inflammatory Biomarkers Including Soluble CD14 and Hyperreflective Foci in DME Patients Treated With Aflibercept (FORESIGHT)
NCT03780361 ·Status: COMPLETED ·Phase: PHASE4
-
The Results of Pars Plana Vitrectomy in Diabetic Macular Edema
NCT03384901 ·Status: UNKNOWN
-
Treatment of Diabetic Macular Edema With Aflibercept and Micropulse Laser
NCT03143192 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Early Anatomical, Physiological, and Clinical Changes in Diabetic Macular Edema After Intravitreal Aflibercept Injection
NCT03453281 ·Status: COMPLETED ·Phase: PHASE4
-
Micropulse Laser in Treatment of Initial and Refractory Cases of Center-Involved Diabetic Macular Edema
NCT07295704 ·Status: RECRUITING
-
Loss to Follow-up in PDR Patients
NCT04018326 ·Status: COMPLETED
-
A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Branch Retinal Vein Occlusion
NCT00308477 ·Status: COMPLETED ·Phase: PHASE1/PHASE2